Literature DB >> 21977113

Comparative study using tuberculin from Cantacuzino Institute versus Statens Serum Institute.

Cristian Cojocaru1, Maria Panescu, Camelia Vasilescu, T Mihaescu.   

Abstract

SETTING: Iasi County, Romania.
OBJECTIVE: To evaluate the efficiency of the tuberculin produced by Cantacuzino Institute (ICB) compared to Statens Serum Institute (SSI) tuberculin in a group of high school students.
DESIGN: 36 subjects were tested simultaneously with two tuberculin tipes. For each student, the left arm was tested with ICB tuberculin, while the right arm was tested with SSI tuberculin. All tests were single blind, and the subjects did not know which tuberculin type was used for each arm. The tuberculin administration sequence was random.
RESULTS: No significant discrepancies were observed in results of both tuberculin reactions. The correlation coefficient was significant (0.95) between both tests (p<0.0001, CI 0.9111-0.9765). Positive results for the tuberculin test were found in 11.1% of the subjects when we used SSI tuberculin. The pain was almost absent at ICB tuberculin injection, comparatively at SSI tuberculin.
CONCLUSION: Tuberculin 2u PPD made by Cantacuzino Institute has the same efficiency as tuberculin PPD RT 23 SSI. The findings of present study recommend, in absence of SSI tuberculin, to use Cantacuzino Institute tuberculin for identification of infections with Mycobacterium tuberculosis complex.

Entities:  

Keywords:  IDR; TB infetion

Year:  2010        PMID: 21977113      PMCID: PMC3150091     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  2 in total

1.  Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak.

Authors:  Katie Ewer; Jonathan Deeks; Lydia Alvarez; Gerry Bryant; Sue Waller; Peter Andersen; Philip Monk; Ajit Lalvani
Journal:  Lancet       Date:  2003-04-05       Impact factor: 79.321

2.  Tuberculosis management in Europe. Task Force of the European Respiratory Society (ERS), the World Health Organisation (WHO) and the International Union against Tuberculosis and Lung Disease (IUATLD) Europe Region.

Authors:  G B Migliori; M C Raviglione; T Schaberg; P D Davies; J P Zellweger; M Grzemska; T Mihaescu; L Clancy; L Casali
Journal:  Eur Respir J       Date:  1999-10       Impact factor: 16.671

  2 in total
  1 in total

1.  Risk of active tuberculosis in patients with inflammatory arthritis receiving TNF inhibitors: a look beyond the baseline tuberculosis screening protocol.

Authors:  Alina Soare; Ana Maria Gheorghiu; Victoria Aramă; Dragoș Bumbăcea; Rucsandra Dobrotă; Raida Oneaţă; Simona Pintilie; Mihaela Milicescu; Ioan Ancuţa; Andrei Martin; Mariana Sasu; Claudia Ciofu; Liviu Macovei; Victor Stoica; Mihai Bojincă; Carina Mihai
Journal:  Clin Rheumatol       Date:  2017-11-17       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.